Chronic Lyme Disease involves multiple infections such as viruses, parasites, bacterial, spirochetes, fungi, and mold. Many practitioners use multiple antibiotic long-term therapy to treat Lyme disease patients. This often leads to further inflammation, organ damage, extensive biofilm formation, neurotoxins, and biotoxins as well as promoting an acidic milieu perfect for the growth of mold, fungi, and parasitic infections.
Silver nanoparticles therapy, on the other hand, provides a broad-spectrum antimicrobial therapy coupled with immune- and inflammation-modulating benefits as well as biofilm disruption capabilities, making it a more effective treatment for Lyme disease.
Silver nanoparticles (Argentyn 23) penetrate bacterial cell walls and cause bacterial cell death, prevent bacterial cell division and DNA replication, and have bactericidal effects against both gram negative and gram positive bacteria. It inhibits bacterial growth, disrupts biofilm colonies, destroys fungi habitation and parasite infections.
Silver nanoparticles provide strong antimicrobial therapy against hundreds of microbes, including bacteria, parasites, fungi, and viruses. Silver nanoparticles can play a powerful role in the complex treatment of chronic Lyme disease and associated infections.
Anyone with chronic Lyme disease should talk with their doctor about adding silver nanoparticles to their therapy.
This articles was presented in the Townsend Letter-July 2016 by Nooshin K. Darvish, ND, FICT, July, 2016, p 48-57.
In addition to this copy of the Townsend letter, we have an extended library in our waiting room area available for our patients to read and explore.
Print